ice-t pain regimen for total laparoscopic hysterectomy

Conditions: Opioid Substitution Treatment

Summary: the purpose of this randomized controlled trial is to determine whether, "ice-t," a multimodal postoperative pain regimen composed of around the clock ice packs, toradol, and tylenol, has improved pain control compared to the standard narcotic based postoperative pain regimen in patients undergoing total laparoscopic gyn surgery.

laparoscopy is a frequently used route for hysterectomy. yet few studies have investigated opioid-sparing postoperative regimens for this common surgery. the study objective was to determine whether ice packs, tylenol, and toradol (ice-t), an opioid-sparing multimodal postoperative pain regimen, has improved pain control compared with a standard opioid-centric postoperative pain regimen in total laparoscopic hysterectomy patients. the study was a randomized controlled trial. it included total laparoscopic hysterectomy postoperative patients that were randomized to the ice-t or standard regimen. the ice-t regimen prescribed scheduled around-the-clock ice-packs, acetaminophen and ketorolac. the standard protocol prescribed as needed ibuprofen and acetaminophen/oxycodone based on pain score. both regimens included intravenous hydromorphone for breakthrough pain. however, subjects in the ice-t group who requested additional narcotic medications prior to postoperative day 4, were prescribed supplemental narcotics in addition to the ice-t regimen. the subjects pain control and quality of recovery were assessed on postoperative day 1 and 4.

Eligibility criteria:
inclusion criteria: the inclusion criteria are the following: * consenting, english speaking women between ages 18 and 80 who will undergo same day laparoscopic gyn surgery at metrohealth medical center * ability to read vas scores * specific procedures include, but are not limited to: * laparoscopic hysterectomy, for uterus 250 g or less * laparoscopic hysterectomy, for uterus 250 g or less; with removal of tube(s), and/or ovary(s) * laparoscopic hysterectomy, for uterus 250 g or less; with removal of tube(s), and/or ovary(s), with repair of enterocele * laparoscopic hysterectomy, for uterus 250 g or less; with repair of enterocele * laparoscopic hysterectomy, for uterus greater than 250 g * laparoscopic hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s) * laparoscopic hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s), with repair of enterocele * laparoscopic hysterectomy, for uterus greater than 250 g; with repair of enterocele exclusion criteria: * history of chronic pelvic pain * abdominal surgery * history of psychiatric disease * currently taking analgesic medications * currently taking sedatives * liver disease * renal disease with crcl \< 60cc/min. * history of burns from application of ice. * women who did not consent for the study. * intraoperative concern for increased blood loss * unable to speak english * unable to understand vas scores * undergoing concomitant abdominal procedures. * allergy to motrin, toradol, percocet, tylenol * active or history of peptic ulcer disease * history of gi bleeding or perforation * hemorrhagic diathesis * severe uncontrolled heart failure * inflammatory bowel disease

Keywords: anti-inflammatory agents non-steroidal